in sale quantity and production cost. Performance Revenue from sale and cost of sale The Company and subsidiary recorded a sales volume of 1,449,290 tons for the year 2018, increased by 66,524 tons
Trade (DIT) The fluctuation of CPO price mentioned above had reflected the Company's business operation in the production and distribution of biodiesel from CPO industry, which is the inherent risk that
price mentioned above had reflected the Company's business operation in the production and distribution of biodiesel from CPO industry, which is the inherent risk that significantly impact on the
biomass increase by Baht 7.5 million as a result from improving of production efficiency, lead to an increase in electricity unit produced for the nine-month period for 2019 comparing to 2018. For Natural
million or 75.16% up from 1Q2019 mainly from higher production capacity of cooked chicken products from new further processing factory. Financial Costs Financial costs of the group include the interest paid
parts businesses and 26.1% increase in dealership businesses respectively whilst industry production was up by 9.7%. The increase in revenue was due to the following reasons: 1) Automotive Parts Business
increase in production volumes resulting in economies of scale. G R OS S P R O F I T a n d G R OS S P R O F I T M A RG I N : Q 3 / 2 0 2 4 K e y F i n a nc i a l H i g h l i g h t s 1 1EBITDA Margin and Net
, another one-off expense was public relation expenses regarding the Initial Public Offering (IPO) in September 2017. Lastly, the establishment of provident fund. Financing Costs The financing costs of
: Information Memorandum on Acquiring of Common Shares in Ekachai International Co., Ltd. To : Managing Director of Stock Exchange of Thailand Ref. : The EKH / CS / 2560/016 Establishment
/ CS / 2560/016 Establishment of New Subsidiary (Revised No.2) on 3 April 2017 The Board of Directors Meeting of Ekachai Medical Care Public Company Limited (the “Company”) No. 1/2018 held on 26th